Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children

Journal of Pediatrics

Volumn 136, Issue 6, 2000, Pages 739-743

  Vajro, Pietro ^a,b   Franzese, Adriana ^a,b   Valerio, Giuliana ^a,b   Iannucci, Maria Pina ^a,b   Aragione, Nunzia ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; TRIACYLGLYCEROL; URSODEOXYCHOLIC ACID;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; ECHOGRAPHY; FATTY LIVER; FEMALE; HUMAN; INTERVIEW; LIVER FUNCTION TEST; LOW CALORY DIET; MALE; OBESITY; PRIORITY JOURNAL; WEIGHT REDUCTION;

EID: 0034049790     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(00)26774-7     Document Type: Article

References (15)

1. 1. Franzese A, Vajro P, Argenziano A, Puzziello A, Iannucci MP, Saviano MC, et al. Liver involvement in obese children: ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 1997;42:1428-32.
2. 2. Baldridge AD, Perez-Atayde AR, Graeme-Cook F, Higgins L, Lavine JE. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr 1995;127:700-4.
3. 3. Kinugasa A, Tsunamoto K, Furukawa N, Sawada T, Kusunoki T, Shimada N. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr 1984;3: 408-14.
4. 4. Vajro P, Fontanella A, Perna C, Orso G, Tedesco M, De Vincenzo A. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr 1994;124:239-41.
5. 5. Wing RR, Greeno CG. Behavioural and psychosocial aspects of obesity and its treatment. Baillieres Clin Endocrinol Metab 1994;8:689-703.
6. 6. Abdemalek M, Ludwig J, Lindor KD. Two cases from the spectrum of non alcoholic steatohepatitis. J Clin Gastroenterol 1995;20:127-30.
7. 7. Laurin J, Lindor KD, Crippin JS, Gossard A, Gores GJ, Ludwig J, et al. Ursodeoxycholic acid or clofibrate in the treatment of non alcohol induced steatohepatitis: a pilot study. Hepatology 1996;23:1464-7.
8. 8. Sheth SB, Gordon FD, Chopra S. Non alcoholic steatohepatitis. Ann Intern Med 1997;126:137-45.
9. 9. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children 1995. Arch Dis Child 1966;41:613-63.
10. 10. Pinto HC, Baptista A, Camilo ME, Valente A, Sargoça A, deMoura MC. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalised patients. Dig Dis Sci 1996;41: 172-9.
11. 11. Oliva L, Beauge F, Choquart D, Montet AM, Guitaoui M, Montet JC. Ursodeoxycholate alleviates alcoholic fatty liver damage in rats. Alcohol Clin Exp Res 1998;22:1538-43.
12. 12. Sherlock S, Dooley J. Diseases of the liver and biliary system. Oxford: Blackwell Sciences Ltd; 1997. p. 431.
13. 13. Fromenty B, Berson A, Pessayre D. Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation. J Hepatol 1997;26(suppl 1):13-22.
14. 14. Lavine JE. Relative antioxidant deficiency in obese children: A weighty contributor to morbidity? J Pediatr 1999;134:132-3.
15. 15. Lavine JE. Treatment of obesity-induced steatohepatitis with vitamin E [abstract]. Gastroenterology 1998;114: L0356.